Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p60v-src and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells

Abstract

We made use of QNR cells transformed by a thermosensitive (tsNY68) strain of the Rous sarcoma virus (RSV) to compare the effect of p60v-src and serum in cultured nerve cells. In this system, both p60v-src heat inactivation and serum removal resulted in growth arrest in G1. In both cases, growth arrest was reversible since cell proliferation was rapidly re-induced following respectively p60v-src renaturation or serum re-addition. However, cells did not fully recover their ability to grow in soft agar, suggesting that, in contrast to the cell cycle machinery, the transforming capacities of these cells have been irreversibly altered. We found that p60v-src kinase activity prevented detachment from the substratum and cell death following serum removal. Thermal inactivation of p60v-src at restrictive temperature (41.5°C), but not serum removal, resulted in dramatic morphological changes, which occured 4 h after temperature shift up to 41.5°C. Later on, typical features of apoptotic cells could be observed. Cell death was greatly reduced by the caspase-3 inhibitor ZVAD.FMK, but not by the caspase-1 inhibitor Ac-YVAD.CHO. Together, these results suggested that p60v-src and serum factors act on distinct pathways, at least in part. In an attempt to identify the signalling pathways involved in the cell response to p60v-src down regulation, we found that Erk and Rac were rapidly inactivated following temperature shift up to 41.5°C. Thus, the combined effects of p60v-src and serum factors on the cytoskeleton dynamics and the apoptosis machinery are essential for full neoplastic transformation of neuroretina cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Adams JM, Cory S . 2001 Trends Biochem Sci. 26: 61–66

  • Aftab DT, Kwan J, Martin GS . 1997 Proc. Natl. Acad. Sci. USA 94: 3028–3033

  • Alema S, Casalbore P, Agostini E, Tato F . 1985 Nature 316: 557–559

  • Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC, Tomaselli KJ . 1997 J. Neurosci. 17: 553–562

  • Brickell PM . 1992 Crit. Rev. Oncogenesis 3: 401–446

  • Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE . 1998 Mol. Cell. Biol. 18: 2553–2558

  • Brown MT, Cooper JA . 1996 Biochimica Biophys. Acta 1287: 121–149

  • Calothy G, Poirier F, Dambrine G, Mignatti P, Combes P, Pessac B . 1980 Cold Spring Harbor Symp. Quant. Biol. 44: 983–990

  • Carragher NO, Fincham VJ, Riley D, Frame M . 2001 J. Biol. Chem. 276: 4270–4275

  • Cartwright CA, Meisler AI, Eckhart W . 1990 Proc. Natl. Acad. Sci. USA 87: 558–562

  • Castellani L, Reedy M, Airey JA, Gallo R, Ciotti MT, Falcone G, Alema S . 1996 J. Cell Sci. 109: 1335–1346

  • Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM, Vogt PK . 1997 Science 276: 1848–1850

  • Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH . 1992 J. Biol. Chem. 267: 9248–9256

  • Cleghon V, Morrison DK . 1994 J. Biol. Chem. 269: 17749–17755

  • Clark EA, King WG, Brugge JS, Symons M, Hynes RO . 1998 J. Cell Biol. 142: 573–586

  • Crisanti-Combes P, Lorinet AM, Girard A, Pessac B, Wasseff M, Calothy G . 1982 Cell Differ. 11: 45–54

  • Dehm S, Senger MA, Bonham K . 2001 FEBS Letters 487: 367–371

  • Denhardt D . 1996 Biochem. J. 316: 729–747

  • Downward J . 1998 Curr. Opin. Genet. Dev. 8: 49–54

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC . 1992 Cell 69: 119–128

  • Fincham VJ, Wyke JA, Frame MC . 1995 Oncogene 10: 2247–2252

  • Fincham VJ, Frame MC . 1998 EMBO J. 17: 81–92

  • Frish SM, Francis H . 1994 J. Cell Biol. 124: 619–626

  • Gavazzi I, Nermut MV, Marchisio PC . 1989 J. Cell Sci. 94: 85–99

  • Gibbs JB, Marshall MS, Skolnick EM, Dixon RA, Vogel US . 1991 J. Biol. Chem. 265: 20437–20442

  • Gillet G, Brun G . 1996 Trends in Microbiol. 4: 312–317

  • Gillet G, Guérin M, Trembleau A, Brun G . 1995 EMBO J. 14: 1372–1381

  • Gillet G, Michel D, Crisanti P, Guerin M, Herault Y, Pessac B, Calothy G, Brun G, Volovitch M . 1993 Oncogene 8: 565–574

  • Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ . 1999 Nat. Genet. 21: 187–190

  • Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J . 2000 Cell Death and Differ. 7: 685–696

  • Jove R, Garber EA, Iba H, Hanafusa H . 1986 J. Virol. 60: 849–857

  • Jove R, Hanafusa H . 1987 Ann. Rev. Cell Biol. 3: 31–56

  • Laemmli UK . 1970 Nature 277: 680–685

  • Mayer BJ, Baltimore D . 1993 Trends Cell Biol. 3: 8–13

  • Mayer T, Meyer M, Janning A, Schiedel AC, Barnekow A . 1999 Oncogene 18: 2117–2128

  • Meijne AM, Ruuls-Van Stalle L, Feltkamp CA, McCarthy JB, Roos E . 1997 Exp. Cell Res. 234: 477–485

  • Muhlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C, Scheurich P, Wajant H . 1998 J. Biol. Chem. 273: 33091–33098

  • Nermut MV, Eason P, Hirst EM, Kellie S . 1991 Exp. Cell Res. 193: 382–397

  • Odajima J, Matsumura I, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T, Kanakura Y . 2000 J. Biol. Chem. 275: 24096–24105

  • Ory S, Munari-Silem Y, Fort P, Jurdic P . 2000 J. Cell Sci. 113: 1177–1188

  • Penuel E, Martin GS . 1999 Mol. Biol. Cell 10: 1693–1703

  • Pessac B, Girard A, Romey G, Crisanti P, Lorinet AM, Calothy G . 1983 Nature 302: 616–618

  • Petch LA, Bockholt SM, Bouton A, Parsons JT, Burridge K . 1995 J. Cell Sci. 108: 1371–1379

  • Peyssonaux, Provot S, Felder-Schmittbuhl MP, Calothy G, Eychenne A . 2000 Mol. Cell. Biol. 20: 7068–7079

  • Poirier F, Calothy G, Karess RE, Erikson E, Hanafusa H . 1982 J. Virol. 42: 780–789

  • Polte TR, Hanks SK . 1997 J. Biol. Chem. 272: 5501–5509

  • Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA . 1986 J. Biol. Chem. 261: 13754–13759

  • Routes JM, Ryan S, Clase A, Miura T, Kuhl A, Potter TA, Cook JL . 2000 J. Immunol. 165: 4522–4527

  • Sahai E, Olson MF, Marshall CJ . 2001 EMBO J. 20: 755–766

  • Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, Collard JG . 1998 J. Cell Biol. 143: 1385–1398

  • Schlessinger J . 2000 Cell 100: 293–296

  • Schwartzberg PL . 1998 Oncogene 17: 1463–1468

  • Sicheri F, Kuriyan J . 1997 Curr. Opin. Structural Biology 7: 777–785

  • Smith MR, DeGudicibus SJ, Stacey DW . 1986 Nature 320: 540–543

  • Sorge LK, Levy BT, Maness PF . 1984 Cell 36: 249–257

  • Soriano P, Montgomery C, Geske R, Bradley A . 1991 Cell 64: 693–702

  • Stein PL, Vogel H, Soriano P . 1994 Genes Dev. 8: 1999–2007

  • Stokoe D, McCormick F . 1997 EMBO J. 16: 2384–2396

  • Sudol M . 1993 The Molecular Basis of Human Cancer Neel B and Kumar R (eds) Futura Publishing Company Inc pp 203–224

    Google Scholar 

  • Taylor SJ, Shalloway D . 1996a BioEssays 18: 9–11

  • Taylor SJ, Shalloway D . 1996b Curr. Biol. 6: 1621–1627

  • Thomas SM, Brugge JS . 1997 Ann. Rev. Cell Biol. 13: 513–609

  • Tominaga T, Sahai E, Chardin P, McCormick F, Courtneidge SA, Alberts AS . 2000 Mol. Cell 5: 13–25

  • Webb BL, Jimenez E, Martin GS . 2000 Mol. Cell. Biol. 20: 9271–9280

  • Wu LW, Hackett PB . 1995 Oncogene 11: 1459–1468

  • Ziogas A, Lorenz IC, Moelling K, Radziwill G . 1998 J. Biol. Chem. 273: 24108–24114

Download references

Acknowledgements

Mrs J Bernaud has to be specially acknowledged for her help for FACS analysis. We thank Dr A Srinavasan, Dr J Collard and Dr S Taylor for plasmids and antibodies. This work has been supported by grants from Association pour la lutte Contre le Cancer (ARC), Ligue Nationale Contre le Cancer (comité du Rhône), Fondation pour la Recherche Médicale, Université Claude Bernard and Association Retina France. AA and SO are recipients of fellowships from the ARC and the Ministère de l'éducation et de la recherche (France), J-R Schmitt was recipient from fellowships from the Ligue Nationale Contre le Cancer and the ARC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Germain Gillet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aouacheria, A., Ory, S., Schmitt, JR. et al. p60v-src and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells. Oncogene 21, 1171–1186 (2002). https://doi.org/10.1038/sj.onc.1205170

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205170

Keywords

This article is cited by

Search

Quick links